Fluidigm microfluidics technology to fuel growth in genomics services SOUTH SAN FRANCISCO, Calif. — MOgene, a leading provider of genomic and bioinformatic services in St. Louis, today announced it has selected Fluidigm’s (NASDAQ:FLDM) Advanta™ assays and microfluidics-based Juno™ system to expand its next-generation sequencing (NGS) services portfolio. Using Fluidigm’s recently released Advanta RNA-Seq NGS Library […]

• Milestone instrument placed with Cenata GmbH in Germany • More than 30 diagnostic assays, including eight FDA approved tests available for the system • Launch of new PowerFecal Pro Kit automating microbiome sample preparation Hilden, Germany, and Germantown, Maryland, January 9, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 2,500th […]

CytomX implements off-the-shelf Genedata workflow platform to accelerate development and manufacture of proprietary biotherapeutic modalities for cancer treatment SAN FRANCISCO (PRWEB) — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that CytomX Therapeutics, a clinical-stage oncology-focused biopharmaceutical company, has licensed Genedata Bioprocess® to act as an integrated workflow backbone for its […]

A new generation of Bionano-based assays to be brought to the clinic by GeneDx SAN DIEGO — Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr® System, a genome imaging platform for ultra-sensitive and ultra-specific genome-wide structural variation detection, today announced the adoption of Saphyr by GeneDx, Inc., […]

Saphyr helps provide a better understanding of ALS, Alzheimer’s disease and Parkinson’s disease SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Mayo Clinic has adopted the Saphyr system. A team led by Dr. Mark Ebbert brought the Saphyr system in-house after determining that Bionano’s technology can provide a deeper understanding of the […]

SOUTH SAN FRANCISCO — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that The University of Michigan Protein Assembly Lab, a hub for collaborative and innovative research at the intersection of synthetic biology, protein engineering and personalized medicine, has chosen the Hyperion™ Imaging […]

  Today, a new, large-scale population genomics project was announced by the Department of Health in Abu Dhabi, UAE.  The programme aims to improve the understanding of the genomics of individuals in the region as part of a personalised medicine initiative. The project is also exploring ways to deliver participants their own genomes as part […]

DAVIE, Fla. — Kaycha Labs, the largest network of cannabis testing labs in the United States, has announced a strategic investment in cutting edge sample testing machinery from Anton Paar, the world’s premier manufacturer of analytical instruments. The new machines will enable Kaycha to move to a fully automated testing process; create a Gold Standard in cannabis and hemp […]

DNAnexus’ FedRAMP-authorized cloud-based platform exemplifies FDA strategy for enhancing the regulatory process through data, technology, and stakeholder engagement. MOUNTAIN VIEW, Calif. – DNAnexus, Inc., the leader in Enterprise Omics Technology, today announced that the U.S. Food and Drug Administration (FDA) has awarded DNAnexus a five-year, $20 million contract to power the precisionFDA Collaborative Omics Environment in the […]

Clinical-stage immuno-oncology company Agenus builds on Genedata’s E2E biopharma discovery system to streamline cancer immunotherapy R&D Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Agenus, a clinical-stage immuno-oncology company developing therapies to fight cancer, has chosen Genedata Biologics® as a part of their antibody R&D workflow platform. […]